Literature DB >> 2354442

Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.

P E Petrides1, S Bock, J Bovens, R Hofmann, G Jakse.   

Abstract

We have analyzed the expression of the genes for the precursors of epidermal growth factor (pro-EGF) and transforming growth factor alpha (proTGF-alpha) as well as for the EGF receptor in tissue specimens of a large number of adult patients with renal cell carcinoma. Since normal kidney tissue was available from the same patients we could directly compare the expression of these genes in tumors with that in adjacent normal renal tissue. Our experiments reveal underexpression of the proEGF gene in all tumors analyzed (21 of 21) and overexpression of the genes for proTGF-alpha (33 of 33 analyzed) and EGF receptor (22 of 23 analyzed) in tumor samples, when compared with normal kidney tissue. The expression of the proTGF-alpha gene appeared to depend on grade and differentiation of the tumor, since well differentiated tumors (grade 1) expressed more proTGF-alpha mRNA than the adjacent normal tissue but significantly less than poorly differentiated tumors (grade 2 or 3), which are the most aggressive ones. In none of these tissue specimens did we find, by Southern analysis, amplification of the proTGF-alpha or EGF receptor gene. Therefore, overexpression of these genes must be due to another effect, perhaps an alteration of their mRNA turnover. Although the EGF receptor gene (c-erbB1) is overexpressed in nearly all carcinomas analyzed, there was no linear coexpression with the proTGF-alpha gene. In contrast, transcription of the proEGF gene was completely turned off in tumor tissue. Although we have found by restriction fragment length polymorphism analysis, in one of three tumor samples, evidence for a somatic mutation within the proEGF gene, we do not know yet, due to the limited number of Southern analyses, whether this somatic mutation is causally involved in the decrease of proEGF mRNA expression and, hence, is representative of renal cell carcinoma. To our knowledge, this is the first observation on primary tumor tissue in humans that upon malignant transformation the gene for a polypeptide growth factor gene is underexpressed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354442

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Impact of Regular Cannabis Use on Biomarkers of Lower Urinary Tract Function.

Authors:  Balachandar Nedumaran; Pratyaydipta Rudra; Jeanette Gaydos; Sushil Kumar; Randall B Meacham; Ellen L Burnham; Anna P Malykhina
Journal:  Urology       Date:  2017-08-18       Impact factor: 2.649

2.  Induction of renal adenocarcinoma by a nonmutated erbB oncogene.

Authors:  C A Taglienti-Sian; B Banner; R J Davis; H L Robinson
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

3.  Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.

Authors:  Gregory J Chen; Matthias A Karajannis; Elizabeth W Newcomb; David Zagzag
Journal:  J Neurooncol       Date:  2010-02-22       Impact factor: 4.130

4.  Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy.

Authors:  B Ljungberg; M Gåfvels; J E Damber
Journal:  Urol Res       Date:  1994

5.  Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.

Authors:  Jiabin An; Matthew B Rettig
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064

7.  Relationship between expression of epidermal growth factor and simian virus 40 T antigen in a line of transgenic mice.

Authors:  R E Lafond; J T Giammalvo; L C Norkin
Journal:  Transgenic Res       Date:  1995-09       Impact factor: 2.788

8.  Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

Authors:  S N Wagner; M J Atkinson; S Thanner; C Wagner; M Schmitt; O Wilhelm; M Rotter; H Höfler
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

9.  Immunoreactive low-molecular-weight epidermal growth factor in urine of patients with renal cell carcinoma.

Authors:  P le Coutre; S Bock; G Jakse; P E Petrides
Journal:  Urol Res       Date:  1992

10.  Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system.

Authors:  G Reifenberger; J Reifenberger; T Bilzer; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.